# |
PMID |
Sentence |
1 |
16369012
|
Three heterodimeric cytokines, interleukin-12 (IL-12), IL-23, and IL-27, as well as IL-18, contribute to the differentiation and expansion of naive CD4(+) T cells.
|
2 |
16369012
|
Supernatant from p2AIL-23-transfected cells induced the release of IL-17 from activated lymphocytes, confirming the presence of bioactive IL-23.
|
3 |
16621986
|
Although IL-23 specifically increased IFN-gamma production by tumor-specific T cells, IFN-gamma itself was not a primary mediator of the vaccine adjuvant effect.
|
4 |
16621986
|
The IL-23-induced antitumor effect and accompanying reversible weight loss were both partially mediated by TNF-alpha.
|
5 |
16621986
|
Under these conditions, it was also clear that enhanced effector function of vaccine-induced CD8(+) T cells, rather than increased T cell number, is a primary mechanism underlying the antitumor effect of IL-23.
|
6 |
18453582
|
However, upon restimulation with rhesus macaque CD154, GA/d-cAMP-activated DCs produced IL-12p40/IL-23.
|
7 |
19161425
|
IL-23 can induce IFN-gamma responses in the lung if IL-12 is not present, but its major role is in supporting the IL-17 response within the lung.
|
8 |
20434781
|
CS-A also up-regulated STAT3 and IL-23 expression and thus increased IL-17 producing T cells.
|
9 |
20504940
|
However, only the IL-22(+) IFN-gamma(-) lung NK subset was observed after stimulation with IL-23.
|
10 |
20504940
|
IL-23 receptor (IL-23R) blocking dramatically inhibited IL-22 production, but not IFN-gamma production.
|
11 |
21084465
|
By using an autovaccine approach, i.e., IL-12p70 cross-linked with ovalbumin and PADRE peptide formulated with the GSK proprietary adjuvant system AS02(V), we could specifically neutralize IL-12 while leaving the IL-23 axis intact.
|
12 |
21039466
|
Both immature and mature MoLCs secreted higher quantities of IL-23 compared with MoDCs and this finding correlated with a higher secretion of IL-17 in co-culture of MoLCs with allogeneic CD4(+) T cells.
|
13 |
21282337
|
Overall, our results suggest the potential of anti-human IL-23 mAbs to improve the immunostimulatory effects of IL-2 and trastuzumab in the current management of some advanced human cancers.
|
14 |
21490151
|
LT enhanced IL-23 and IL-1? production from DCs via activation of ERK MAPK and IL-1? secretion through activation of caspase-1 and the NLRP3 inflammasome.
|
15 |
19252500
|
In contrast, dectin-1 signaling mostly induced IL-23 and proinflammatory cytokines and augmented T(H)17 and T(H)1-mediated autoimmune responses in vivo.
|
16 |
21424108
|
After administrations of TNBS, vaccinated mice had significantly less body weight loss and a significant decrease of inflammatory scores, collagen deposition and expression of p40, IL-12, IL-23, IL-17, TNF, iNOS and Bcl-2 in colon tissues, compared with carrier and saline groups.
|
17 |
21746859
|
Here, we show that CD40L transduction of DCs results in the induction of interleukin-12p40 (IL-12p40), IL-12p70, and IL-23.
|
18 |
21746859
|
Antigen-specific recall responses in CD4-deficient mice were critically dependent on IL-12p40 and IL-23p19 expression in DCs and were not affected by the lack of IL-12p35.
|
19 |
19386801
|
Functional evaluation of the expanded number of CD4+ IL-23R+ cells in the presence of different cytokines with anti-CD3/CD28 revealed that all cytokines used (IL-2, IL-7, IL-12, IL-15, and IL-23) increased the amount of IFN-gamma secreted by IL-23R+ CD4+ cells at different levels.
|
20 |
22059995
|
Modified peptides induced higher IL-13 production than the wild-type, while the conserved peptides P16 and P19 induced the highest IFN-? and IL-13 and/or sCD30 release, respectively.
|